ReviewEye and vision (London, England)2017
Pharmacological treatments of presbyopia: a review of modern perspectives.
Review in Eye and vision (London, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 36 citations in OpenAlex.
- Nitrogen-containing FDA-approved drugs in 2025: synthesis, significance and therapeutic applications.RSC advances · 2026Review
- Non-invasive measuring of biopotentials of the ciliary muscle during accommodation in emmetropes.Scientific reports · 2025Article
- Pilocarpine 1% for Improved Near Vision in Pseudophakic Patients.Journal of ophthalmic & vision research · 2025Article
- Effects of Miosis on the Visual Acuity Space under Varying Conditions of Contrast and Ambient Luminance in Presbyopia.Journal of clinical medicine · 2024Article
- Visual outcome after small incision cataract surgery of patients in a Kenyan Hospital Contributors.African health sciences · 2023Article
- Pharmacological treatment of presbyopia: A systematic review.European journal of translational myology · 2022Article
- Pharmacological Treatment in Presbyopia.Journal of clinical medicine · 2022Review
- Determination of the Standard Visual Criterion for Diagnosing and Treating Presbyopia According to Subjective Patient Symptoms.Journal of clinical medicine · 2021Article
- Improvement of Presbyopia Using a Mixture of Traditional Chinese Herbal Medicines, Including Cassiae Semen, Wolfberry, andEvidence-based complementary and alternative medicine : eCAM · 2021Article
- Presbyopia Treatment With Eye Drops: An Eight Year Retrospective Study.Translational vision science & technology · 2020Article
- Translational Preclinical Pharmacologic Disease Models for Ophthalmic Drug Development.Pharmaceutical research · 2019Review
- Latanoprost could exacerbate the progression of presbyopia.PloS one · 2019Article
- Erratum to: Pharmacological treatments of presbyopia: a review of modern perspectives.Eye and vision (London, England) · 2017Article
- Patients' attitudes and beliefs to presbyopia and its correction.Journal of optometryArticle
- Correction of presbyopia: An integrated update for the practical surgeon.Taiwan journal of ophthalmologyReview
Corrections and comments
- Erratum issued
Authors and funding
3 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionPresbyopia affects people from the 4
resultsSeveral ophthalmic eye drops compounds solutions have been described in peer-reviewed papers or presented in ophthalmological tabloids and congresses. Each topical treatment deals with drug combinations aimed to modify one or more factors involved in the accommodative process and have been proposed to be instilled either monocularly or binocularly. It remains unclear how much each drug in the final combined form is involved in the achievement of the outcome and contributes to it.
conclusionDespite the lack of a completely well understood mechanism, pharmacological control of presbyopia seems to be a possible and very attractive alternative for presbyopic patients. The studies mentioned in this review are to be considered pilot investigations as they involve either a small number of subjects or are single case series. Complete studies are needed to confirm which will be the more effective pharmacological compound for the treatment of presbyopia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.